| For: | Mao SJ, Hou SX, He R, Zhang LK, Wei DP, Bi YQ, Jin H. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. World J Gastroenterol 2005; 11(20): 3075-3079 [PMID: 15918193 DOI: 10.3748/wjg.v11.i20.3075] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i20/3075.htm |
| Number | Citing Articles |
| 1 |
M. Alagawany, S.S. Elnesr, M.R. Farag. Use of liquorice (Glycyrrhiza glabra) in poultry nutrition: Global impacts on performance, carcass and meat quality. World's Poultry Science Journal 2019; 75(2) doi: 10.1017/S0043933919000059
|
| 2 |
Mahfoozur Rahman, Kainat Alam, Rafida Ilyas, Sarwar Beg. Nanoformulation Strategies for Cancer Treatment. 2021; doi: 10.1016/B978-0-12-821095-6.00015-X
|
| 3 |
Aihua Lin, Yiming Liu, Yu Huang, Jingbo Sun, Zhifeng Wu, Xian Zhang, Qineng Ping. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. International Journal of Pharmaceutics 2008; 359(1-2) doi: 10.1016/j.ijpharm.2008.03.039
|
| 4 |
Raman Rohilla, Tarun Garg, Jitender Bariwal, Amit K. Goyal, Goutam Rath. Development, optimization and characterization of glycyrrhetinic acid–chitosan nanoparticles of atorvastatin for liver targeting. Drug Delivery 2016; 23(7) doi: 10.3109/10717544.2014.977460
|
| 5 |
Juan Guan, Wei Chen, Min Yang, Ercan Wu, Jun Qian, Changyou Zhan. Regulation of in vivo delivery of nanomedicines by herbal medicines. Advanced Drug Delivery Reviews 2021; 174 doi: 10.1016/j.addr.2021.04.015
|
| 6 |
Luciano A. Stecanella, Antonio P. R. Bitencourt, Gustavo Richter Vaz, Eride Quarta, José O. C. Silva Júnior, Alessandra Rossi. Glycyrrhizic Acid and Its Hydrolyzed Metabolite 18β-Glycyrrhetinic Acid as Specific Ligands for Targeting Nanosystems in the Treatment of Liver Cancer. Pharmaceutics 2021; 13(11) doi: 10.3390/pharmaceutics13111792
|
| 7 |
Guangming Gong, Feng Zhi, Kaikai Wang, Xiaolei Tang, Ahu Yuan, Lili Zhao, Dawei Ding, Yiqiao Hu. Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting. Nanotechnology 2011; 22(29) doi: 10.1088/0957-4484/22/29/295603
|
| 8 |
Deepak Mishra, Nivrati Jain, Vaibhav Rajoriya, Ashish K Jain. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine. Journal of Pharmacy and Pharmacology 2014; 66(8) doi: 10.1111/jphp.12235
|
| 9 |
Xitong Su, Lei Wu, Mingming Hu, Wenxiang Dong, Meng Xu, Peng Zhang. Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomedicine & Pharmacotherapy 2017; 95 doi: 10.1016/j.biopha.2017.08.123
|
| 10 |
Elmira Karami, Maryam Mesbahi Moghaddam, Fatemeh Kazemi-Lomedasht. Use of Albumin for Drug Delivery as a Diagnostic and Therapeutic Tool. Current Pharmaceutical Biotechnology 2024; 25(6) doi: 10.2174/1389201024666230807161200
|
| 11 |
Yuxiang Wang, Wenzhen Wang, Hailu Yao, Jingjing Wang, Fenghe Yang, Yu Zhang, Guanhua Du, Guang Han. Glycyrrhizic Acid-Based Liposome for Tumor-Targeted Delivery of Cantharidin. ACS Applied Nano Materials 2024; 7(1) doi: 10.1021/acsanm.3c05019
|
| 12 |
Zi-wen Zhao, Ming-hui Cai, Ping Wang, Ding-ding Wang, Yang Liu, Yu-zhou Chen. Application of glycyrrhizic acid and glycyrrhetinic acid in the drug delivery system. Journal of Drug Delivery Science and Technology 2024; 97 doi: 10.1016/j.jddst.2024.105754
|
| 13 |
Wei Peng, Shumin Cheng, Zhihang Bao, Youjing Wang, Wei Zhou, Junxian Wang, Qingling Yang, Changjie Chen, Wenrui Wang. Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis. Biomedicine & Pharmacotherapy 2021; 137 doi: 10.1016/j.biopha.2021.111342
|
| 14 |
A.A. D’Souza, P.V. Devarajan . HEPATIC TARGETING – ADDRESSING VITAL THERAPEUTIC NEEDS. INDIAN DRUGS 2015; 52(10) doi: 10.53879/id.52.10.10480
|
| 15 |
AiHua Lin, Jun Chen, YiMing Liu, Shigui Deng, Zhifeng Wu, Yu Huang, QiNeng Ping. Preparation and evaluation ofN-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Drug Development and Industrial Pharmacy 2009; 35(11) doi: 10.3109/03639040902939197
|
| 16 |
Qin Tian, Wei Wang, XiaoTing He, XiaoCui Zhu, Wei Huang, ChuangNian Zhang, Zhi Yuan, XueSi Chen. Glycyrrhetinic acid-modified nanoparticles for drug delivery: Preparation and characterization. Chinese Science Bulletin 2009; 54(18) doi: 10.1007/s11434-009-0249-5
|
| 17 |
Ashim Malhotra, Gulnaz Javan, Shivani Soni. Advanced Surfaces for Stem Cell Research. 2016; doi: 10.1002/9781119242642.ch14
|
| 18 |
L.‐Y. Zha, Z.‐R. Xu, M.‐Q. Wang, L.‐Y. Gu. Chromium nanoparticle exhibits higher absorption efficiency than chromium picolinate and chromium chloride in Caco‐2 cell monolayers. Journal of Animal Physiology and Animal Nutrition 2008; 92(2) doi: 10.1111/j.1439-0396.2007.00718.x
|
| 19 |
|
| 20 |
Zhen Li, Lan Hao, Pei Yuan, Wenjing Hu, Liangke Zhang. Encapsulation of honokiol-loaded nanoparticles in lecithin microbubbles for targeted tumor therapy. RSC Advances 2016; 6(60) doi: 10.1039/C6RA10047C
|
| 21 |
Piyali Dey, Somasree Ray, Pronobesh Chattopadhyay. Design and Applications of Theranostic Nanomedicines. 2023; doi: 10.1016/B978-0-323-89953-6.00005-2
|
| 22 |
|
| 23 |
Shi-Hui Liu, Qing-Zhen Wang, Tao Liu, Ru Bai, Man-Man Ma, Qiao-Lin Liu, Hui-Ge Zhou, Jing Liu, Mei Wang. Enhanced Glioblastoma Selectivity of Harmine via the Albumin Carrier. Journal of Biomedical Nanotechnology 2022; 18(4) doi: 10.1166/jbn.2022.3321
|
| 24 |
Meysam Dehghani, Hadi Zare-Zardini, Hossein Eslami, Mojtaba Ansari, Farzaneh Fesahat. Anticancer efficacy of albumin nanoparticles co-loaded with silver nanoparticles and 5FU in animal model of colon cancer. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-19075-7
|
| 25 |
Anisha A. D’Souza, Vishvesh M. Joshi, Padma V. Devarajan. Targeted Drug Delivery : Concepts and Design. Advances in Delivery Science and Technology 2015; doi: 10.1007/978-3-319-11355-5_6
|
| 26 |
Tomoaki Kurosaki, Saki Kawanabe, Yukinobu Kodama, Shintaro Fumoto, Koyo Nishida, Hiroo Nakagawa, Norihide Higuchi, Tadahiro Nakamura, Takashi Kitahara, Hitoshi Sasaki. Hepatic Gene Delivery System Electrostatically Assembled with Glycyrrhizin. Molecular Pharmaceutics 2014; 11(5) doi: 10.1021/mp400398f
|
| 27 |
Yang Chu, Dan Li, Yi-Fan Luo, Xiao-Jin He, Ming-Yan Jiang. Preparation and In Vitro Evaluation of Glycyrrhetinic Acid-Modified Curcumin-Loaded Nanostructured Lipid Carriers. Molecules 2014; 19(2) doi: 10.3390/molecules19022445
|
| 28 |
Mingxiang Chang, Meimei Wu, Hanmin Li. Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice. Drug Delivery 2018; 25(1) doi: 10.1080/10717544.2018.1526227
|
| 29 |
S. Sripriyalakshmi, Pinkybel Jose, Aswathy Ravindran, C. H. Anjali. Recent Trends in Drug Delivery System Using Protein Nanoparticles. Cell Biochemistry and Biophysics 2014; 70(1) doi: 10.1007/s12013-014-9896-5
|
| 30 |
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 2019; 25 doi: 10.1016/j.mattod.2018.10.040
|
| 31 |
Islam A. Hassanin, Ahmed O. Elzoghby. Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs. Expert Opinion on Drug Delivery 2020; 17(10) doi: 10.1080/17425247.2020.1813713
|
| 32 |
Alaa F. Bakr, Ping Shao, Mohamed A. Farag. Recent advances in glycyrrhizin metabolism, health benefits, clinical effects and drug delivery systems for efficacy improvement; a comprehensive review. Phytomedicine 2022; 99 doi: 10.1016/j.phymed.2022.153999
|
| 33 |
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opinion on Drug Delivery 2021; 18(4) doi: 10.1080/17425247.2021.1854223
|
| 34 |
Shayeri Chatterjee Ganguly, Soumya Ganguly, Beduin Mahanti, Purna Chandra Pal, Swarnajit Dutta, Subhabrota Majumdar. Elucidating the anti-inflammatory potential of nanoscaled polymeric-albumin blends of garcinol: Optimization, in silico, in vitro, and in vivo studies. International Journal of Biological Macromolecules 2025; 303 doi: 10.1016/j.ijbiomac.2025.140469
|
| 35 |
Lili Shi, Cui Tang, Chunhua Yin. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma. Biomaterials 2012; 33(30) doi: 10.1016/j.biomaterials.2012.06.072
|
| 36 |
Nivrati Jain, Vaibhav Rajoriya, Prateek Kumar Jain, Ashish Kumar Jain. Lactosaminated-N-succinyl chitosan nanoparticles for hepatocyte-targeted delivery of acyclovir. Journal of Nanoparticle Research 2014; 16(1) doi: 10.1007/s11051-013-2136-x
|
| 37 |
Wei Huang, Wei Wang, Ping Wang, Qin Tian, Chuangnian Zhang, Chunhong Wang, Zhi Yuan, Min Liu, Haiying Wan, Hua Tang. Glycyrrhetinic acid-modified poly(ethylene glycol)–b-poly(γ-benzyl l-glutamate) micelles for liver targeting therapy. Acta Biomaterialia 2010; 6(10) doi: 10.1016/j.actbio.2010.04.021
|
| 38 |
Islam A. Hassanin, Mohamed Teleb, Adnan A. Bekhit, Kadria A. Elkhodairy, Sherine N. Khattab, Ahmed O. Elzoghby. Advanced Nanoformulations. 2023; doi: 10.1016/B978-0-323-85785-7.00022-X
|